FI970696L - Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi - Google Patents
Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi Download PDFInfo
- Publication number
- FI970696L FI970696L FI970696A FI970696A FI970696L FI 970696 L FI970696 L FI 970696L FI 970696 A FI970696 A FI 970696A FI 970696 A FI970696 A FI 970696A FI 970696 L FI970696 L FI 970696L
- Authority
- FI
- Finland
- Prior art keywords
- compositions
- methods
- ribonucleic acids
- oligonucleotide conjugates
- degrading
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title 1
- 230000000593 degrading effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920002477 rna polymer Polymers 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH269494 | 1994-09-02 | ||
| PCT/EP1995/003408 WO1996007667A1 (de) | 1994-09-02 | 1995-08-30 | Oligonukleotidkonjugate, zusammensetzungen und verfahren zur spaltung von ribonukleinsäuren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI970696A0 FI970696A0 (fi) | 1997-02-19 |
| FI970696L true FI970696L (fi) | 1997-02-19 |
Family
ID=4239485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI970696A FI970696L (fi) | 1994-09-02 | 1997-02-19 | Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0778845A1 (fi) |
| JP (1) | JPH10505353A (fi) |
| AU (1) | AU3519095A (fi) |
| CA (1) | CA2197785A1 (fi) |
| FI (1) | FI970696L (fi) |
| HU (1) | HUT77034A (fi) |
| NO (1) | NO970885L (fi) |
| WO (1) | WO1996007667A1 (fi) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5798491A (en) * | 1993-06-09 | 1998-08-25 | Board Of Regents, The University Of Texas System | Multi-mechanistic chemical cleavage using certain metal complexes |
| US5714328A (en) * | 1995-06-07 | 1998-02-03 | Board Of Regents, The University Of Texas System | RNA photocleavage using texaphyrins |
| WO1998007733A1 (en) * | 1996-08-20 | 1998-02-26 | Pharmacyclics, Inc. | Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof |
| US6022959A (en) * | 1996-08-20 | 2000-02-08 | Pharmacyclics, Inc. | Nucleic acids internally-derivatized with a texaphyrin metal complex and uses thereof |
| US6255476B1 (en) * | 1999-02-22 | 2001-07-03 | Pe Corporation (Ny) | Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports |
| KR101040700B1 (ko) * | 2006-11-16 | 2011-06-10 | 주식회사 엘지화학 | 테레프탈알데히드의 정제방법 |
| NZ580457A (en) | 2007-04-06 | 2012-03-30 | Neurocrine Biosciences Inc | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| CL2008000986A1 (es) | 2007-04-06 | 2008-10-17 | Neurocrine Biosciences Inc | COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5559207A (en) * | 1989-03-06 | 1996-09-24 | Board Of Regents, University Of Texas | Texaphyrin metal complex mediated ester hydrolysis |
-
1995
- 1995-08-30 WO PCT/EP1995/003408 patent/WO1996007667A1/de not_active Application Discontinuation
- 1995-08-30 HU HU9701971A patent/HUT77034A/hu unknown
- 1995-08-30 JP JP8509173A patent/JPH10505353A/ja active Pending
- 1995-08-30 EP EP95931942A patent/EP0778845A1/de not_active Withdrawn
- 1995-08-30 CA CA002197785A patent/CA2197785A1/en not_active Abandoned
- 1995-08-30 AU AU35190/95A patent/AU3519095A/en not_active Abandoned
-
1997
- 1997-02-19 FI FI970696A patent/FI970696L/fi unknown
- 1997-02-27 NO NO970885A patent/NO970885L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0778845A1 (de) | 1997-06-18 |
| FI970696A0 (fi) | 1997-02-19 |
| CA2197785A1 (en) | 1996-03-14 |
| NO970885D0 (no) | 1997-02-27 |
| JPH10505353A (ja) | 1998-05-26 |
| AU3519095A (en) | 1996-03-27 |
| WO1996007667A1 (de) | 1996-03-14 |
| HUT77034A (hu) | 1998-03-02 |
| NO970885L (no) | 1997-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962799L (fi) | Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö | |
| HK1012398A1 (en) | Phosphonomonoester nucleic acids, methods for their preparation and their use | |
| FI973363L (fi) | Nukleiinihappoja sisältävä koostumus, sen valmistus ja käyttö | |
| AU2206800A (en) | Targeted molecular bar codes and methods for using the same | |
| EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
| DE69840172D1 (de) | Rna exportelement | |
| IL133293A0 (en) | Pharmaceutical compositions comprising cyclodextrins | |
| HK1031374A1 (en) | Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives. | |
| NL300150I2 (nl) | 4 "-Gesubstitueerde 9-deoxo-9A-AZA-9A-homoërythromycine-A-derivaten. | |
| FI963692L (fi) | Menetelmiä ja koostumuksia, jotka ovat käyttökelpoisia angiogeneesin inhibointiin | |
| AU4683099A (en) | Targeted oligonucleotide conjugates | |
| FI971176L (fi) | DNA-fotopilkkominen käyttäen teksapyriinejä | |
| AU2215995A (en) | Freeze-dried compositions comprising rna | |
| DE69529288D1 (de) | Wasserlösliche polyen-konjugate | |
| NO20000231D0 (no) | Dolastatin-15-derivater | |
| PT1042449E (pt) | Microorganismo, processo para obtencao do mesmo e aditivo para forragem | |
| DE59811528D1 (de) | Hypolipidämische Propanolaminderivate | |
| IL137162A0 (en) | 2,3,4,5-tetrahydro -1h- [1,4]-benzodiazepine -3- hydroxamic acids as matrix metalloproteinase inhibitors | |
| FI972264L (fi) | Betaiinituote, menetelmä sen valmistamiseksi, ja sen käyttö | |
| FI953578L (fi) | Ksylanaasi, sitä tuottava mikro-organismi, DNA-molekyyli, menetelmä ksylanaasin valmistamiseksi ja sen käyttö | |
| FI972548A0 (fi) | Oligonukleotidi-dendrimeerikonjugaatit | |
| FI970696L (fi) | Oligonukleotidikonjugaatit, koostumukset ja menetelmät ribonukleiinihappojen hajoittamiseksi | |
| EE04398B1 (et) | Asendatud 1,2,3,4,5,6-heksahüdro-2,6-metano-3-bensasotsiin-10-oolid, nende valmistamise meetod ja kasutamine ravimitena | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| FI955399L (fi) | Polyolikoostumus, menetelmä sen valmistamiseksi ja sen käytöt |